HIV Citation List: March 27 - April 9, 2015

PubMed Citations

1. From the Traditional Chinese Medicine Plant Schisandra chinensis New Scaffolds Effective on HIV-1 Reverse Transcriptase Resistant to Non-nucleoside Inhibitors. Xu, L., N. Grandi, C. Del Vecchio, D. Mandas, A. Corona, D. Piano, F. Esposito, C. Parolin, and E. Tramontano. Journal of Microbiology, 2015. 53(4): p. 288-293. PMID[25740376].
[PubMed]. HIV_0327-040915.

2. miR-146a Controls CXCR4 Expression in a Pathway That Involves PLZF and Can Be Used to Inhibit HIV-1 Infection of CD4(+) T Lymphocytes. Quaranta, M.T., E. Olivetta, M. Sanchez, I. Spinello, R. Paolillo, C. Arenaccio, M. Federico, and C. Labbaye. Virology, 2015. 478: p. 27-38. PMID[25705792].

[PubMed]. HIV_0327-040915.

3. Synthesis, Conformational Studies, and Biological Properties of Phosphonomethoxyethyl Derivatives of Nucleobases with a Locked Conformation via a Pyrrolidine Ring. Pohl, R., L. Postova Slavetinska, W.S. Eng, D.T. Keough, L.W. Guddat, and D. Rejman. Organic & Biomolecular Chemistry, 2015.

13(16): p. 4693-4705. PMID[25798893].
[PubMed]. HIV_0327-040915.

4. Investigations of Possible Prodrug Structures for 2-(2-Mercaptophenyl)tetrahydropyrimidines: Reductive Conversion from anti-HIV Agents with Pyrimidobenzothiazine and Isothiazolopyrimidine Scaffolds. Okazaki, S., S. Oishi, T. Mizuhara, K. Shimura, H. Murayama, H. Ohno, M. Matsuoka, and N. Fujii. Organic & Biomolecular Chemistry, 2015. 13(16): p. 4706-4713. PMID[25800792].

[PubMed]. HIV_0327-040915.

5. Identification of anti-HIV Agents with a Novel Benzo[4,5]isothiazolo[2,3-a]Pyrimidine Scaffold. Okazaki, S., T. Mizuhara, K. Shimura, H. Murayama, H. Ohno, S. Oishi, M. Matsuoka, and N. Fujii. Bioorganic & Medicinal Chemistry, 2015. 23(7): p. 1447-1452. PMID[25744188].
[PubMed]. HIV_0327-040915.

6. A Trypsin Inhibitor from Rambutan Seeds with Antitumor, anti-HIV-1 Reverse Transcriptase, and Nitric Oxide-inducing Properties. Fang, E.F. and T.B. Ng. Applied Biochemistry and Biotechnology, 2015. 175(8): p. 3828-3839. PMID[25820360].
[PubMed]. HIV_0327-040915.

7. Insights into the Mechanism of Inhibition of CXCR4: Identification of Piperidinylethanamine Analogs as anti-HIV-1 Inhibitors. Das, D., K. Maeda, Y. Hayashi, N. Gavande, D.V. Desai, S.B. Chang, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2015. 59(4): p. 1895-1904. PMID[25583709].
[PubMed]. HIV_0327-040915.

ISI Web of Knowledge Citations

8. The CRISPR/Cas9 System Inactivates Latent HIV-1 Proviral DNA. Zhu, W.J., R.Y. Lei, Y. Le Duff, J. Li, F. Guo, M.A. Wainberg, and C. Liang. Retrovirology, 2015. 12(22): 7pp. ISI[000350853400001].
[WOS.] HIV_0327-040915.

9. Acyclovir Phosphoramidates as Potential anti-HIV Drugs. Zakirova, N.F., I.L. Karpenko, M.M. Prokofjeva, C. Vanpouille, V.S. Prassolov, A.V. Shipitsyn, and S.N. Kochetkov. Russian Chemical Bulletin, 2014. 63(5): p. 1192-1196. ISI[000350143000025].
[WOS.] HIV_0327-040915.

10. Sesquiterpenoid Tropolone Glycosides from Liriosma ovata. Ma, J., R.S. Pawar, E. Grundel, E.P. Mazzola, C.D. Ridge, T. Masaoka, S.F.J. Le Grice, J. Wilson, J.A. Beutler, and A.J. Krynitsky. Journal of Natural Products, 2015. 78(2): p. 315-319. ISI[000350328600021].
[WOS.] HIV_0327-040915.

11. Diastereoselective Synthesis of (1,3-Dioxan-4-yl) Pyrimidine and Purin nucleoside Analogues. Battisti, U.M., C. Sorbi, A. Quotadamo, S. Franchini, A. Tait, D. Schols, L.S. Jeong, S.K. Lee, J. Song, and L. Brasili. European Journal of Organic Chemistry, 2015(6): p. 1235-1245. ISI[000349972700010].
[WOS.] HIV_0327-040915.

12. Synthesis, Structure-Activity Relationship and Molecular Docking of Cyclohexenone Based Analogous as Potent Non-Nucleoside Reverse-Transcriptase Inhibitors. Nazar, M.F., M.I. Abdullah, A. Badshah, A. Mahmood, U.A. Rana, and S.U.D. Khan. Journal of Molecular Structure, 2015. 1086: p. 8-16. ISI[000350518400002].
[WOS]. HIV_0327-040915.

13. Discovery of Novel 5-Fluoro-N-2,N(4-)diphenylpyrimidine-2,4-diamines as Potent Inhibitors against CDK2 and CDK9. Gao, J.D., C. Fang, Z.Y. Xiao, L. Huang, C.H. Chen, L.T. Wang, and K.H. Lee. MedChemComm, 2015. 6(3): p. 444-454. ISI[000351095400009].
[WOS]. HIV_0327-040915.

Patent Citations

14. Thioether Prodrug Compositions as anti-HIV and Anti-retroviral Agents. Appella, D., P. Kumar, N. Shank, and M.D. Hassink. Patent. 2015. 2014-US54019 2015035003: 45pp.

[Patent]. HIV_0327-040915.

15. Antisense-based Small RNA Agents Targeting the Gag Open Reading Frame of HIV-1 RNA. Gatignol, A. and R. Scarborough. Patent. 2015. 2014-CA50814 2015027334: 66pp.

[Patent]. HIV_0327-040915.

16. Preparation of gem-Difluoro Heterobicyclic Compounds as HIV-1 Protease Inhibitors. Ghosh, A.K., H. Mitsuya, and S. Yashchuk. Patent. 2015. 2014-14483043 20150072958: 46pp.

[Patent]. HIV_0327-040915.

17. Preparation of Amino acid-containing Nucleotide and Nucleoside Triphosphates as Antiviral Agents. Liotta, D.C., G.R. Painter, G.R. Bluemling, and A. De La Rosa. Patent. 2015. 2014-US54930 2015038596: 331pp.

[Patent]. HIV_0327-040915.

18. Preparation of Triazole Derivatives as anti-AIDS Agents. Lu, S., H. Zhang, J. Yu, and X. Yu. Patent. 2015. 2014-10696031 104387379: 16pp.

[Patent]. HIV_0327-040915.